Tanios S Bekaii-Saab

Featured in: Favicon

nature.com Favicon

sagepub.com Favicon

tandfonline.com Favicon

thelancet.com Favicon

liebertpub.com Favicon

healio.com Favicon

newsbreak.com Favicon

amegroups.com Favicon

futuremedicine.com Favicon

cancernetwork.com + 8 more

Articles

Advancing Research and Targeting Genomic Alterations in Pancreatic Cancer

Nov 25, 2024 | cancernetwork.com | Tanios S Bekaii-Saab

In a conversation with CancerNetwork® during Pancreatic Cancer Awareness Month, Tanios S. Bekaii-Saab, MD, spoke about various developments in the pancreatic cancer treatment field.
Further Genomic Analysis May Expand the Pancreatic Cancer Field

Nov 8, 2024 | cancernetwork.com | Tanios S Bekaii-Saab

In a conversation with CancerNetwork® during Pancreatic Cancer Awareness Month, Tanios S. Bekaii-Saab, MD, highlighted the importance of profiling pancreatic cancer tumors for genomic analysis among all eligible patients to help inform treatment decision-making in the field.
Dr Bekaii-Saab on the Role of Liquid and Tissue Biopsies for Newly Diagnosed GI Cancers

Nov 4, 2024 | onclive.com | Tanios S Bekaii-Saab

CommentaryVideoNovember 4, 2024Author(s):Tanios Bekaii-Saab, MD, FACP, discusses the role of liquid and tissue biopsies in newly diagnosed gastrointestinal cancers.
Dr Bekaii-Saab on Frontline Treatment Considerations for BRCA1/2+ Pancreatic Cancer

Oct 25, 2024 | onclive.com | Tanios S Bekaii-Saab

CommentaryVideoOctober 25, 2024Author(s):Tanios Bekaii-Saab, MD, FACP, discusses the evolving treatment paradigm for BRCA1- and BRCA2-positive pancreatic cancer in the first-line setting.
Dr Bekaii-Saab on the Final Analysis of MOUNTAINEER in HER2+ CRC

Aug 8, 2024 | onclive.com | Tanios S Bekaii-Saab

CommentaryVideoAugust 8, 2024Author(s):Tanios Bekaii-Saab, MD, FACP, discusses final results from the MOUNTAINEER trial in HER2+ metastatic colorectal cancer.
Dr Bekaii-Saab on the Benefits of Multidisciplinary Conferences in GI Cancer Care

Aug 7, 2024 | onclive.com | Tanios S Bekaii-Saab

CommentaryVideoAugust 7, 2024Author(s):Tanios Bekaii-Saab, MD, FACP, discusses the benefits of multidisciplinary conferences within the gastrointestinal cancer treatment field.
Dr Bekaii-Saab on the Future of Treatment For Patients With GI Cancer

Jul 31, 2024 | onclive.com | Tanios S Bekaii-Saab

CommentaryVideoJuly 31, 2024Author(s):Tanios Bekaii-Saab, MD, FACP, discusses the future of treatment within the gastrointestinal cancers armamentarium.
Dr Bekaii-Saab on the Ongoing Development of Targeted Therapies in GI Malignancies

Jul 25, 2024 | onclive.com | Tanios S Bekaii-Saab

CommentaryVideoJuly 25, 2024Author(s):Tanios Bekaii-Saab, MD, FACP, discusses next-generation sequencing and the development of RAS-targeted therapies in gastrointestinal cancers.
Treating Early- and Intermediate-Stage Hepatocellular Carcinoma

Apr 1, 2024 | cancernetwork.com | Rahul Gosain |Rohit Gosain |Tanios S Bekaii-Saab

2 Commerce Drive Cranbury, NJ 08512
Nivolumab plus Ipilimumab vs Chemotherapy as First-line Treatment for Microsatellite Instability-High/Mismatch Repair Deficient Metastatic Colorectal Cancer: First Results of the CheckMate 8HW Study

Jan 31, 2024 | onclive.com | Tanios S Bekaii-Saab

Nivolumab plus Ipilimumab vs Chemotherapy as First-line Treatment for Microsatellite Instability-High/Mismatch Repair Deficient Metastatic Colorectal Cancer: First Results of the CheckMate 8HW StudyIn his discussion of the CHECKMATE 8HW trial, Dr. Tanios Bekaii-Saab examined the efficacy of chemotherapy versus nivolumab plus ipilimumab as the initial treatment for metastatic colorectal cancer with high microsatellite instability and deficient mismatch repair.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →